Prof. Nicholas Hart discusses the findings and clinical implications of the Home Oxygen Therapy – Home Mechanical Ventilation (HOT-HMV) trial, which offers new hope to patients with COPD. For a review of a symposium presented at ERS 2016, plus the HOT-HMV study findings presented at ATS and published in JAMA in June 2017, please click here.
Speaker disclosure: Nicholas Hart reports grants from Guy’s & St Thomas’ Charity, during the conduct of the study; grants from Philips Respironics, ResMed, B&D Electromedical and Fisher-Paykel; non-financial support from Philips Respironics RT Meeting (MyoTrace) and personal fees from Fisher-Paykel, outside the submitted work. In addition, Nicholas Hart has a patent for MyoTrace pending and he is on the Pulmonary Research Advisory Board for Philips. His Lane Fox Clinical Respiratory Physiology Research Group has received unrestricted grants (managed by Guy’s & St Thomas’ Foundation Trust) from Philips Respironics, Philips, ResMed, Fisher-Paykel and B&D Electromedical. Philips Respironics and Philips Research are contributing to the development of the MyoTrace Technology.
Filmed at the American Thoracic Society (ATS) International Conference, Washington DC, US, May 2017.